SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-059815
Filing Date
2023-05-12
Accepted
2023-05-12 16:45:15
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 tm2315614-1_s3.htm S-3 411321
2 EXHIBIT 4.3 tm2021693d2_ex4-3.htm EX-4.3 567339
3 EXHIBIT 5.1 tm2315614d2_ex5-1.htm EX-5.1 57431
4 EXHIBIT 23.1 tm2021693d2_ex23-1.htm EX-23.1 2717
5 EX-FILING FEES tm2315614d2_ex-filingfees.htm EX-FILING FEES 61271
6 GRAPHIC lg_appliedtherapeutics-4c.jpg GRAPHIC 74583
  Complete submission text file 0001104659-23-059815.txt   1200969
Mailing Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017
Business Address 545 5TH AVENUE, SUITE 1400 NEW YORK NY 10017 212-220-9319
Applied Therapeutics Inc. (Filer) CIK: 0001697532 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-271887 | Film No.: 23916600
SIC: 2834 Pharmaceutical Preparations